Marico Q4 net up 7% on revenue growth

Marico share price fell 6 percent intraday after weak operational performance

Published: May 2, 2018

g_105413_saugatagupta_bg_280x210.jpgSaugata Gupta, MD and CEO, Marico
Image: Vikas Khot

FMCG major Marico has reported net profit growth of 7.2 percent year-on-year at Rs 183.2 crore for the quarter ended March 2018, backed by double digit revenue growth.

Profit in corresponding period of last fiscal was at Rs 170.9 crore.

Revenue from operations during the quarter increased 11.7 percent to Rs 1,480.1 crore compared to Rs 1,324.6 crore in same period previous fiscal, driven by price hikes in the Coconut Oil portfolio.

Domestic business grew by 12 percent YoY and the international business showed a 13 percent growth YoY.

"The India business volumes grew by a modest 1 percent, while the International business posted a very healthy constant currency growth of 16 percent (volume growth of 5 percent)," the company said.

Parachute and Saffola witnessed a volume decline of 5 percent YoY and 1 percent, respectively. However Value Added Hair Oils portfolio clocked 11 percent YoY volume growth.

Marico said gross margins (down 522 bps YoY) continued to remain under pressure owing to the unrelenting inflation in copra prices against a benign input cost environment in the base quarter.

Operating profit or EBITDA (earnings before interest, tax, depreciation and amortisation) declined 6.1 percent to Rs 252.3 crore and margin contracted 320 basis points to 17.1 percent compared to corresponding quarter last fiscal.

"Marico's Q4FY18 results were below our estimates on both revenue & earnings front. Though the copra prices have been cooled off by around 10 percent from the peak in January 2018, we believe its impact on price cuts would only be reflected in next two quarters. However we remain positive on the growth prospects of the company’s core hair oil / edible oil business," ICICI Securities said.

Marico share price fell 6 percent after weak operational performance. At 15:22 hours IST, the stock price was quoting at Rs 317.90, down Rs 14.95, or 4.49 percent on the BSE. 
 
 
The article first appeared here.

Show More
Post Your Comment
Required
Required, will not be published
All comments are moderated
We need to accept failure to progress: Samuel West
Biotech's unlikely hero: The government